Drug profile · INN
lamivudine, nevirapine, and stavudine
LAMIVUDINE, NEVIRAPINE, AND STAVUDINE
lamivudine, nevirapine, and stavudine (LAMIVUDINE, NEVIRAPINE, AND STAVUDINE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Drug details — lamivudine, nevirapine, and stavudine
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
lamivudine, nevirapine, and stavudine (LAMIVUDINE, NEVIRAPINE, AND STAVUDINE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is lamivudine, nevirapine, and stavudine?
lamivudine, nevirapine, and stavudine (LAMIVUDINE, NEVIRAPINE, AND STAVUDINE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for lamivudine, nevirapine, and stavudine?
LAMIVUDINE, NEVIRAPINE, AND STAVUDINE is a marketed brand name for lamivudine, nevirapine, and stavudine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lamivudine, nevirapine, and stavudine?
lamivudine, nevirapine, and stavudine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.